Topic: St. Jude Medical Inc.
WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel decided not to recommend CardioMEMS implantable heart device for treating heart failure because supporting clinical research appeared biased by human intervention.Six out of 10 members of the FDA advisory committee of outside ...
St. Jude Medical says European regulators have cleared its Ensite Contact technology platformSt. Jude Medical Inc. said Thursday European Union regulators approved its Ensite Contact technology, which is designed to improve procedures used in treatment of a serious heart condition.St. Jude said ...
St. Jude Medical Inc. said Tuesday it has received Food and Drug Administration and European CE Mark approval for its QuickFlex family of left-heart leads to treat heart failure patients.. Shares of St. Paul, Minn.-based St. Jude fell 20 cents to $39.79.. ...
From Around the Web
Video Gallery
-
Company Profile: St Jude Medical Inc ...
The company's main products are pacemakers and implantable cardioverter ...2010-05-20 -
St. Jude Medical Announces FDA Clearance ...
The first-of-its-kind Epiducer(TM) lead delivery system enables physicians to ...2011-07-12 -
St. Jude Medical Randomized Clinical Trial ...
Animation of the St. Jude Medical Genesis(TM) neurostimulation system ...2011-06-23
